Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jorge Diaz

Clinical Cardiac Electrophysiology Lake Mary, FL Medical Doctor

NPI 1487663373 CMS profile 340180

1331 S International Pkwy Ste 1261, Lake Mary, FL 32746

Open in the dashboard

General payments

$158,477

732 records reported · program years 2019–2025

Research payments

$19,064

Paid to them · 20 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$27,586 paid to institutions, not to them · program years 2019–2022

Through program year 2025, Jorge Diaz of Lake Mary, FL is reported in the CMS Open Payments database as having received $158,477 across 732 general payments and $19,064 in research payments paid to them. Separately, studies naming them as principal investigator received $27,586 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 93rd percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $51,208 167
2024 General $40,515 132
2023 General $19,513 82
2022 General $5,432 54
2021 General $10,849 89
2020 General $5,832 59
2020 Research $6,069 8
2019 General $25,129 149
2019 Research $12,994 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jorge Diaz
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Jorge Diaz were reported at $51,208. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Jorge Diaz Clinical Cardiac Electrophysiology median Middle half National median
2019 $25,129 $2,361 $585–$8,260 $163
2020 $5,832 $993 $247–$4,351 $114
2021 $10,849 $1,185 $326–$4,739 $132
2022 $5,432 $2,073 $554–$6,789 $149
2023 $19,513 $2,568 $759–$8,159 $160
2024 $40,515 $2,557 $703–$7,403 $164
2025 $51,208 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $152,681 610 payments
  2. Medtronic, Inc. $2,207 32 payments
  3. Boston Scientific Corporation $2,156 28 payments
  4. Medtronic Vascular, Inc. $310 33 payments
  5. Biosense Webster, Inc. $296 4 payments
  6. Biotronik Inc. $288 8 payments
  7. Impulse Dynamics (USA) Inc. $151 1 payment
  8. Amgen Inc. $123 2 payments
  9. Sumitomo Pharma America, Inc. $98 4 payments
  10. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $36 3 payments
  11. Other $130 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $112,750 136 payments
  2. Travel and Lodging $21,838 67 payments
  3. Food and Beverage $20,165 521 payments
  4. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $2,160 5 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,550 2 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $14 1 payment
Products named General payments · program years 2019–2025
  1. AVEIR Structural Heart $32,065 38 payments
  2. AMPLATZER AMULET $32,001 115 payments
  3. Ensite Cardiac Mapping System $21,725 64 payments
  4. JETI ALL IN ONE NON-STERILE KIT $15,016 13 payments
  5. AVEIR Cardiac Rhythm Management $10,487 30 payments
  6. Advisor Catheter $6,485 9 payments
  7. ACCENT $5,338 7 payments
  8. GALLANT $4,286 12 payments
  9. ADVISOR $3,706 3 payments
  10. AVEIR Cardiac Rhythm Management $2,425 28 payments
  11. Other $23,250 393 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Abbott Laboratories $19,064 20 payments

Prescribing to Medicare patients

Part D · data year 2024 · 18 drugs

Part D claims

1,003

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$189,305

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

38.3%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 118 $139,691
Entresto Sacubitril/Valsartan Brand 18 $20,890
Xarelto Rivaroxaban Brand 13 $14,333
Amiodarone Hcl Generic 90 $3,500
Sotalol Sotalol Hcl Brand 132 $2,917
Metoprolol Succinate Generic 157 $2,042
Dofetilide Generic 30 $1,920
Clopidogrel Clopidogrel Bisulfate Brand 103 $904
Metoprolol Tartrate Generic 105 $833
Flecainide Acetate Generic 27 $481

The 10 drugs with the highest cost, of 18 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 84 billing codes

Paid by Medicare

$363,548

Medicare's payments for the services billed

Medicare patients

800

Average age 78

Services billed

4,079

356 women, 444 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 72%
Atrial fibrillation 69%
Arthritis 58%
Heart failure 53%
Chronic kidney disease 49%
Diabetes 47%
COPD 41%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
GEMTESA
  • Sumitomo Pharma America, Inc. $25
$25 — —
CAMZYOS
  • E.R. Squibb & Sons, L.L.C. $15
$15 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

752 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record